Published in Cancer Weekly, April 6th, 2004
This patent is the parent to a series of applications that significantly broaden Artemis Medical's proprietary position in the breast biopsy marking arena. The patent contains 10 claims. Artemis has had two patents issued year-to-date, bringing the company's total number of issued patents to 13 in the United States.
This new patent relates to methods for marking a biopsy site using a swellable, bioresorbable body having a radiopaque marker carried by the resorbable body. The patent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.